This study investigates the prognostic impact of tumor spread through air spaces (STAS) in early-stage synchronous multiple primary lung adenocarcinoma (sMPLA) and its interaction with surgical strategies. Among 131 patients with cT1-3N0M0 sMPLA, STAS was detected in 52 percent, including 16 percent with STAS in both tumors (bi-STAS).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
June 26, 2025
June 24, 2025
This video demonstrates a low-cost method for implementing augmented reality in robotic segmentectomy using open-source software and affordable hardware.
Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer
June 5, 2025
This study evaluated the SHURUI single-port (SP) robotic system for uniportal robotic-assisted thoracic surgery (RATS) in lung cancer patients.
June 5, 2025
This article discusses a promising diagnostic approach aimed at improving patient selection for immune checkpoint inhibitor (ICI) therapies, particularly in non-small cell lung cancer (NSCLC). The current reliance on PD-L1 immunohistochemistry (IHC) as a biomarker has limited sensitivity and specificity.
May 7, 2025
This video demonstrates an approach for sentinel lymph node mapping in sublobar anatomic resections.
Prevalence of Invasive Lung Cancer in Pure Ground Glass Nodules Less Than 30 mm: A Systematic Review
December 19, 2024
This article examines the malignancy potential of pure ground-glass nodules (pGGNs) under 30 mm, challenging the notion that these nodules carry minimal invasive cancer risk.
December 12, 2024
At the 2024 WTS conference, Dr. Marianna Papageorge spoke with Dr. Nicole Geissen about Dr. Geissen's study on lung cancer screening.
December 5, 2024
This article provides a consensus-based approach for determining the resectability and optimal management strategies for locally advanced non-small cell lung cancer (NSCLC).
November 7, 2024
Recently, the CALGB 140503 trial and the JCOG0802/WJOG4607L showed the non-inferiority of sublobar resections compared to lobectomy for <2cm non-small cell lung cancer.
November 7, 2024
This article explores the disparities in access to minimally invasive surgery (MIS) for stage I non-small cell lung cancer (NSCLC) based on socioeconomic status.